Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
7
×
life sciences
medicare
7
×
national
7
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
novartis
startups
amgen
biogen
cancer
cancer immunotherapy
clinical trials
drug prices
eli lilly
gene therapy
alzheimer's disease
What
bio
roundup
companies
drug
alzheimer’s
gene
hasn’t
life
new
patients
pharmaceutical
price
science
talk
terms
acquisitions
albert
appetite
approval
arrival
becker
biggest
billions
biogen’s
biopharmaceutical
biotech
black
bourla
bread
butter
buyout
cancer
cash
ceo
company
congress
convo
crispr
days
democrats
Language
unknown
unset
Current search:
national
×
medicare
×
deals
×
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel